{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T18:35:09Z","timestamp":1793039709210,"version":"4.5.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2019,12,12]],"date-time":"2019-12-12T00:00:00Z","timestamp":1576108800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,12,12]],"date-time":"2019-12-12T00:00:00Z","timestamp":1576108800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100003107","name":"Bundesministerium f\u00fcr Gesundheit","doi-asserted-by":"publisher","award":["ZMVI5\u20132514ATA004"],"award-info":[{"award-number":["ZMVI5\u20132514ATA004"]}],"id":[{"id":"10.13039\/501100003107","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1007\/s00228-019-02797-9","type":"journal-article","created":{"date-parts":[[2020,1,23]],"date-time":"2020-01-23T09:06:46Z","timestamp":1579770406000},"page":"439-448","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Personalising drug safety\u2014results from the multi-centre prospective observational study on Adverse Drug Reactions in Emergency Departments (ADRED)"],"prefix":"10.1007","volume":"76","author":[{"given":"Katja S.","family":"Just","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harald","family":"Dormann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"B\u00f6hme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marlen","family":"Schurig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina L.","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Steffens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Dunow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bettina","family":"Plank-Kiegele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristin","family":"Ettrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Seufferlein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingo","family":"Gr\u00e4ff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svitlana","family":"Igel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Severin","family":"Schricker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon U.","family":"Jaeger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Schwab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1566-8156","authenticated-orcid":false,"given":"Julia C.","family":"Stingl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,12,12]]},"reference":[{"issue":"6","key":"2797_CR1","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1001\/jama.2010.1112","volume":"304","author":"N Tang","year":"2010","unstructured":"Tang N, Stein J, Hsia RY, Maselli JH, Gonzales R (2010) Trends and characteristics of US emergency department visits, 1997-2007. JAMA 304(6):664\u2013670","journal-title":"JAMA"},{"issue":"5","key":"2797_CR2","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1136\/emj.2010.099226","volume":"28","author":"JA Lowthian","year":"2011","unstructured":"Lowthian JA, Curtis AJ, Cameron PA, Stoelwinder JU, Cooke MW, McNeil JJ (2011) Systematic review of trends in emergency department attendances: an Australian perspective. Emerg Med J 28(5):373\u2013377","journal-title":"Emerg Med J"},{"issue":"13","key":"2797_CR3","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1056\/NEJMp068194","volume":"355","author":"AL Kellermann","year":"2006","unstructured":"Kellermann AL (2006) Crisis in the emergency department. N Engl J Med 355(13):1300\u20131303","journal-title":"N Engl J Med"},{"issue":"7456","key":"2797_CR4","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1136\/bmj.329.7456.15","volume":"329","author":"M Pirmohamed","year":"2004","unstructured":"Pirmohamed M, James S, Meakin S, Green C, Scott AK, Walley TJ, Farrar K, Park BK, Breckenridge AM (2004) Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients. BMJ 329(7456):15\u201319. https:\/\/doi.org\/10.1136\/bmj.329.7456.15","journal-title":"BMJ"},{"issue":"4","key":"2797_CR5","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/s00228-002-0467-0","volume":"58","author":"S Schneeweiss","year":"2002","unstructured":"Schneeweiss S, Hasford J, Gottler M, Hoffmann A, Riethling AK, Avorn J (2002) Admissions caused by adverse drug events to internal medicine and emergency departments in hospitals: a longitudinal population-based study. Eur J Clin Pharmacol 58(4):285\u2013291. https:\/\/doi.org\/10.1007\/s00228-002-0467-0","journal-title":"Eur J Clin Pharmacol"},{"issue":"4","key":"2797_CR6","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1002\/pds.1565","volume":"17","author":"CS van der Hooft","year":"2008","unstructured":"van der Hooft CS, Dieleman JP, Siemes C, Aarnoudse AJ, Verhamme KM, Stricker BH, Sturkenboom MC (2008) Adverse drug reaction-related hospitalisations: a population-based cohort study. Pharmacoepidemiol Drug Saf 17(4):365\u2013371. https:\/\/doi.org\/10.1002\/pds.1565","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"17","key":"2797_CR7","doi-asserted-by":"publisher","first-page":"1890","DOI":"10.1001\/archinternmed.2008.3","volume":"168","author":"AJ Leendertse","year":"2008","unstructured":"Leendertse AJ, Egberts AC, Stoker LJ, van den Bemt PM (2008) Frequency of and risk factors for preventable medication-related hospital admissions in the Netherlands. Arch Intern Med 168(17):1890\u20131896. https:\/\/doi.org\/10.1001\/archinternmed.2008.3","journal-title":"Arch Intern Med"},{"issue":"15","key":"2797_CR8","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1001\/jama.279.15.1200","volume":"279","author":"J Lazarou","year":"1998","unstructured":"Lazarou J, Pomeranz BH, Corey PN (1998) Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA 279(15):1200\u20131205","journal-title":"JAMA"},{"issue":"15","key":"2797_CR9","doi-asserted-by":"publisher","first-page":"251","DOI":"10.3238\/arztebl.2018.0251","volume":"115","author":"AM Schurig","year":"2018","unstructured":"Schurig AM, Bohme M, Just KS, Scholl C, Dormann H, Plank-Kiegele B, Seufferlein T, Graff I, Schwab M, Stingl JC (2018) Adverse drug reactions (ADR) and emergencies. Dtsch Arztebl Int 115(15):251\u2013258. https:\/\/doi.org\/10.3238\/arztebl.2018.0251","journal-title":"Dtsch Arztebl Int"},{"issue":"15","key":"2797_CR10","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.1001\/jama.296.15.1858","volume":"296","author":"DS Budnitz","year":"2006","unstructured":"Budnitz DS, Pollock DA, Weidenbach KN, Mendelsohn AB, Schroeder TJ, Annest JL (2006) National surveillance of emergency department visits for outpatient adverse drug events. JAMA 296(15):1858\u20131866. https:\/\/doi.org\/10.1001\/jama.296.15.1858","journal-title":"JAMA"},{"issue":"2","key":"2797_CR11","doi-asserted-by":"publisher","first-page":"161","DOI":"10.2165\/00002018-200629020-00006","volume":"29","author":"CS van Der Hooft","year":"2006","unstructured":"van Der Hooft CS, Sturkenboom MC, van Grootheest K, Kingma HJ, Stricker BHC (2006) Adverse drug reaction-related hospitalisations. Drug Saf 29(2):161\u2013168","journal-title":"Drug Saf"},{"issue":"12","key":"2797_CR12","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1007\/s002280050582","volume":"54","author":"R Raschetti","year":"1999","unstructured":"Raschetti R, Morgutti M, Menniti-Ippolito F, Belisari A, Rossignoli A, Longhini P, La Guidara C (1999) Suspected adverse drug events requiring emergency department visits or hospital admissions. Eur J Clin Pharmacol 54(12):959\u2013963","journal-title":"Eur J Clin Pharmacol"},{"issue":"9","key":"2797_CR13","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1007\/s40264-016-0444-7","volume":"39","author":"MT Angamo","year":"2016","unstructured":"Angamo MT, Chalmers L, Curtain CM, Bereznicki LR (2016) Adverse-drug-reaction-related hospitalisations in developed and developing countries: a review of prevalence and contributing factors. Drug Saf 39(9):847\u2013857. https:\/\/doi.org\/10.1007\/s40264-016-0444-7","journal-title":"Drug Saf"},{"issue":"6","key":"2797_CR14","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1067\/mem.2001.119456","volume":"38","author":"CM Hohl","year":"2001","unstructured":"Hohl CM, Dankoff J, Colacone A, Afilalo M (2001) Polypharmacy, adverse drug-related events, and potential adverse drug interactions in elderly patients presenting to an emergency department. Ann Emerg Med 38(6):666\u2013671","journal-title":"Ann Emerg Med"},{"issue":"1","key":"2797_CR15","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.amjopharm.2006.03.002","volume":"4","author":"JK Nguyen","year":"2006","unstructured":"Nguyen JK, Fouts MM, Kotabe SE, Lo E (2006) Polypharmacy as a risk factor for adverse drug reactions in geriatric nursing home residents. Am J Geriatr Pharmacother 4(1):36\u201341","journal-title":"Am J Geriatr Pharmacother"},{"key":"2797_CR16","unstructured":"EMA (2017) Guideline on good pharmacovigilance practices (GVP), Annex I - definitions. http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Scientific_guideline\/2013\/05\/WC500143294.pdf. Accessed 6 Dec 2017"},{"issue":"9242","key":"2797_CR17","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1016\/S0140-6736(00)03167-6","volume":"356","author":"UA Meyer","year":"2000","unstructured":"Meyer UA (2000) Pharmacogenetics and adverse drug reactions. Lancet 356(9242):1667\u20131671","journal-title":"Lancet"},{"issue":"18","key":"2797_CR18","doi-asserted-by":"publisher","first-page":"2270","DOI":"10.1001\/jama.286.18.2270","volume":"286","author":"KA Phillips","year":"2001","unstructured":"Phillips KA, Veenstra DL, Oren E, Lee JK, Sadee W (2001) Potential role of pharmacogenomics in reducing adverse drug reactions: a systematic review. JAMA 286(18):2270\u20132279","journal-title":"JAMA"},{"issue":"3","key":"2797_CR19","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1007\/s00228-013-1630-5","volume":"70","author":"C Pedros","year":"2014","unstructured":"Pedros C, Quintana B, Rebolledo M, Porta N, Vallano A, Arnau JM (2014) Prevalence, risk factors and main features of adverse drug reactions leading to hospital admission. Eur J Clin Pharmacol 70(3):361\u2013367. https:\/\/doi.org\/10.1007\/s00228-013-1630-5","journal-title":"Eur J Clin Pharmacol"},{"issue":"21","key":"2797_CR20","doi-asserted-by":"publisher","first-page":"2002","DOI":"10.1056\/NEJMsa1103053","volume":"365","author":"DS Budnitz","year":"2011","unstructured":"Budnitz DS, Lovegrove MC, Shehab N, Richards CL (2011) Emergency hospitalizations for adverse drug events in older Americans. N Engl J Med 365(21):2002\u20132012","journal-title":"N Engl J Med"},{"issue":"1","key":"2797_CR21","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1177\/2042098615615472","volume":"7","author":"AH Lavan","year":"2016","unstructured":"Lavan AH, Gallagher P (2016) Predicting risk of adverse drug reactions in older adults. Ther Adv Drug Saf 7(1):11\u201322","journal-title":"Ther Adv Drug Saf"},{"issue":"2","key":"2797_CR22","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1046\/j.1365-2125.2003.01875.x","volume":"57","author":"PA Routledge","year":"2004","unstructured":"Routledge PA, O'mahony M, Woodhouse K (2004) Adverse drug reactions in elderly patients. Br J Clin Pharmacol 57(2):121\u2013126","journal-title":"Br J Clin Pharmacol"},{"key":"2797_CR23","unstructured":"The WHO-UMC System. https:\/\/www.who-umc.org\/media\/2768\/standardised-case-causality-assessment.pdf. Accessed 12 June 2017"},{"key":"2797_CR24","unstructured":"ICH post-approval safety data management: definitions and standards for expedited reporting. http:\/\/www.ich.org\/fileadmin\/Public_Web_Site\/ICH_Products\/Guidelines\/Efficacy\/E2D\/Step4\/E2D_Guideline.pdf. Accessed 26 July 2018"},{"key":"2797_CR25","unstructured":"WHO International Classification of Diseases, Version 10. http:\/\/www.who.int\/classifications\/icd\/icd10updates\/en\/. Accessed 14 Sept 2018"},{"key":"2797_CR26","unstructured":"WHO Collaborating Centre for Drug Statistics Methodology, Health NIoP ATC\/DDD Index 2018. https:\/\/www.whocc.no\/atc_ddd_index\/. Accessed 26 July 2018"},{"issue":"3","key":"2797_CR27","doi-asserted-by":"publisher","first-page":"P118","DOI":"10.1093\/geronb\/52B.3.P118","volume":"52","author":"VH Menec","year":"1997","unstructured":"Menec VH, Chipperfield JG (1997) The interactive effect of perceived control and functional status on health and mortality among young-old and old-old adults. J Gerontol B Psychol Sci Soc Sci 52(3):P118\u2013P126","journal-title":"J Gerontol B Psychol Sci Soc Sci"},{"issue":"4","key":"2797_CR28","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1093\/gerona\/gln045","volume":"64","author":"CA Zizza","year":"2009","unstructured":"Zizza CA, Ellison KJ, Wernette CM (2009) Total water intakes of community-living middle-old and oldest-old adults. J Gerontol A Biol Sci Med Sci 64(4):481\u2013486","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"3","key":"2797_CR29","doi-asserted-by":"publisher","first-page":"M146","DOI":"10.1093\/gerona\/56.3.M146","volume":"56","author":"LP Fried","year":"2001","unstructured":"Fried LP, Tangen CM, Walston J, Newman AB, Hirsch C, Gottdiener J, Seeman T, Tracy R, Kop WJ, Burke G (2001) Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci 56(3):M146\u2013M157","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"2","key":"2797_CR30","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1002\/pds.3663","volume":"24","author":"F Meier","year":"2015","unstructured":"Meier F, Maas R, Sonst A, Patapovas A, Muller F, Plank-Kiegele B, Pfistermeister B, Schoffski O, Burkle T, Dormann H (2015) Adverse drug events in patients admitted to an emergency department: an analysis of direct costs. Pharmacoepidemiol Drug Saf 24(2):176\u2013186. https:\/\/doi.org\/10.1002\/pds.3663","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"5","key":"2797_CR31","doi-asserted-by":"publisher","first-page":"e026771","DOI":"10.1136\/bmjopen-2018-026771","volume":"9","author":"PJ Liao","year":"2019","unstructured":"Liao PJ, Mao CT, Chen TL, Deng ST, Hsu KH (2019) Factors associated with adverse drug reaction occurrence and prognosis, and their economic impacts in older inpatients in Taiwan: a nested case-control study. BMJ Open 9(5):e026771. https:\/\/doi.org\/10.1136\/bmjopen-2018-026771","journal-title":"BMJ Open"},{"issue":"8","key":"2797_CR32","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1111\/j.1532-5415.1997.tb02964.x","volume":"45","author":"JT Hanlon","year":"1997","unstructured":"Hanlon JT, Schmader KE, Koronkowski MJ, Weinberger M, Landsman PB, Samsa GP, Lewis IK (1997) Adverse drug events in high risk older outpatients. J Am Geriatr Soc 45(8):945\u2013948","journal-title":"J Am Geriatr Soc"},{"issue":"11","key":"2797_CR33","doi-asserted-by":"publisher","first-page":"2227","DOI":"10.1111\/jgs.13702","volume":"63","author":"DM Fick","year":"2015","unstructured":"Panel AGSBCUE, Fick DM, Semla TP, Beizer J, Brandt N, Dombrowski R, DuBeau CE, Eisenberg W, Epplin JJ, Flanagan N (2015) American Geriatrics Society 2015 updated beers criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc 63(11):2227\u20132246","journal-title":"J Am Geriatr Soc"},{"issue":"1","key":"2797_CR34","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/1472-6904-7-9","volume":"7","author":"H Patel","year":"2007","unstructured":"Patel H, Bell D, Molokhia M, Srishanmuganathan J, Patel M, Car J, Majeed A (2007) Trends in hospital admissions for adverse drug reactions in England: analysis of national hospital episode statistics 1998\u20132005. BMC Clin Pharmacol 7(1):9","journal-title":"BMC Clin Pharmacol"},{"issue":"6","key":"2797_CR35","doi-asserted-by":"publisher","first-page":"454","DOI":"10.2165\/00003088-199733060-00004","volume":"33","author":"BA Sproule","year":"1997","unstructured":"Sproule BA, Naranjo CA, Bremner KE, Hassan PC (1997) Selective serotonin reuptake inhibitors and CNS drug interactions. Clin Pharmacokinet 33(6):454\u2013471","journal-title":"Clin Pharmacokinet"},{"issue":"3","key":"2797_CR36","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1111\/j.1365-2125.2005.02529.x","volume":"61","author":"E Perucca","year":"2006","unstructured":"Perucca E (2006) Clinically relevant drug interactions with antiepileptic drugs. Br J Clin Pharmacol 61(3):246\u2013255","journal-title":"Br J Clin Pharmacol"},{"issue":"8","key":"2797_CR37","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1111\/j.1532-5415.1996.tb01865.x","volume":"44","author":"J Doucet","year":"1996","unstructured":"Doucet J, Chassagne P, Trivalle C, Landrin I, Pauty M, Kadri N, M\u00e9nard J, Bercoff E (1996) Drug-drug interactions related to hospital admissions in older adults: a prospective study of 1000 patients. J Am Geriatr Soc 44(8):944\u2013948","journal-title":"J Am Geriatr Soc"},{"issue":"8","key":"2797_CR38","doi-asserted-by":"publisher","first-page":"683","DOI":"10.2165\/00002512-200825080-00005","volume":"25","author":"HM Hosia-Randell","year":"2008","unstructured":"Hosia-Randell HM, Muurinen SM, Pitk\u00e4l\u00e4 KH (2008) Exposure to potentially inappropriate drugs and drug-drug interactions in elderly nursing home residents in Helsinki, Finland. Drugs Aging 25(8):683\u2013692","journal-title":"Drugs Aging"},{"issue":"4","key":"2797_CR39","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s00228-017-2373-5","volume":"74","author":"L Zhou","year":"2018","unstructured":"Zhou L, Rupa AP (2018) Categorization and association analysis of risk factors for adverse drug events. Eur J Clin Pharmacol 74(4):389\u2013404. https:\/\/doi.org\/10.1007\/s00228-017-2373-5","journal-title":"Eur J Clin Pharmacol"},{"issue":"20","key":"2797_CR40","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.1001\/jama.2016.16201","volume":"316","author":"N Shehab","year":"2016","unstructured":"Shehab N, Lovegrove MC, Geller AI, Rose KO, Weidle NJ, Budnitz DS (2016) US emergency department visits for outpatient adverse drug events, 2013-2014. Jama 316(20):2115\u20132125","journal-title":"Jama"},{"issue":"6","key":"2797_CR41","doi-asserted-by":"publisher","first-page":"e0178626","DOI":"10.1371\/journal.pone.0178626","volume":"12","author":"G Scripcaru","year":"2017","unstructured":"Scripcaru G, Mateus C, Nunes C (2017) Adverse drug events-analysis of a decade. A Portuguese case-study, from 2004 to 2013 using hospital database. PLoS One 12(6):e0178626. https:\/\/doi.org\/10.1371\/journal.pone.0178626","journal-title":"PLoS One"},{"key":"2797_CR42","doi-asserted-by":"publisher","unstructured":"Dormann H, Sonst A, Muller F, Vogler R, Patapovas A, Pfistermeister B, Plank-Kiegele B, Kirchner M, Hartmann N, Burkle T, Maas R (2013) Adverse drug events in older patients admitted as an emergency: the role of potentially inappropriate medication in elderly people (PRISCUS). Dtsch Arztebl Int 110(13):213\u2013219. https:\/\/doi.org\/10.3238\/arztebl.2013.0213","DOI":"10.3238\/arztebl.2013.0213"},{"issue":"4","key":"2797_CR43","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1007\/s41999-018-0071-1","volume":"9","author":"Francesca Cerreta","year":"2018","unstructured":"Cerreta F, Padr\u00e3o A, Skibicka-Stepien I, Strampelli A, de Orbe Izquierdo MS (2018) Medicines for older people: assessment and transparency at the European Medicines Agency regarding cardiovascular and antithrombotic medicinal products. Eur Geriatr Med 9(4):415\u2013418","journal-title":"European Geriatric Medicine"},{"issue":"4","key":"2797_CR44","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.amjopharm.2007.12.002","volume":"5","author":"ER Hajjar","year":"2007","unstructured":"Hajjar ER, Cafiero AC, Hanlon JT (2007) Polypharmacy in elderly patients. Am J Geriatr Pharmacother 5(4):345\u2013351. https:\/\/doi.org\/10.1016\/j.amjopharm.2007.12.002","journal-title":"Am J Geriatr Pharmacother"},{"issue":"11","key":"2797_CR45","doi-asserted-by":"publisher","first-page":"755","DOI":"10.7326\/0003-4819-147-11-200712040-00006","volume":"147","author":"DS Budnitz","year":"2007","unstructured":"Budnitz DS, Shehab N, Kegler SR, Richards CL (2007) Medication use leading to emergency department visits for adverse drug events in older adults. Ann Intern Med 147(11):755\u2013765","journal-title":"Ann Intern Med"},{"issue":"24","key":"2797_CR46","doi-asserted-by":"publisher","first-page":"2867","DOI":"10.1001\/jama.2008.892","volume":"300","author":"DM Qato","year":"2008","unstructured":"Qato DM, Alexander GC, Conti RM, Johnson M, Schumm P, Lindau ST (2008) Use of prescription and over-the-counter medications and dietary supplements among older adults in the United States. JAMA 300(24):2867\u20132878","journal-title":"JAMA"},{"issue":"3","key":"2797_CR47","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1001\/jama.287.3.337","volume":"287","author":"DW Kaufman","year":"2002","unstructured":"Kaufman DW, Kelly JP, Rosenberg L, Anderson TE, Mitchell AA (2002) Recent patterns of medication use in the ambulatory adult population of the United States: the Slone survey. JAMA 287(3):337\u2013344","journal-title":"JAMA"},{"issue":"9","key":"2797_CR48","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1001\/jama.289.9.1107","volume":"289","author":"JH Gurwitz","year":"2003","unstructured":"Gurwitz JH, Field TS, Harrold LR, Rothschild J, Debellis K, Seger AC, Cadoret C, Fish LS, Garber L, Kelleher M (2003) Incidence and preventability of adverse drug events among older persons in the ambulatory setting. JAMA 289(9):1107\u20131116","journal-title":"JAMA"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-019-02797-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00228-019-02797-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-019-02797-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,11]],"date-time":"2020-12-11T00:25:41Z","timestamp":1607646341000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00228-019-02797-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,12]]},"references-count":48,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["2797"],"URL":"https:\/\/doi.org\/10.1007\/s00228-019-02797-9","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,12]]},"assertion":[{"value":"15 April 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study was approved by the responsible ethical committee of the University of Bonn (202\/15) and reviewed positively by the respective ethical committees of the study centres of the Universities of Erlangen-N\u00fcrnberg (43_16Bc), T\u00fcbingen (113\/16) and Ulm (493\/2016BO1).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from individual participants included in the study described in the manuscript.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}